Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ) has shared an announcement.
Beijing Tong Ren Tang Chinese Medicine Co announced a board meeting scheduled for August 22, 2025, to approve the interim results for the first half of the year and consider dividend payments. This meeting is significant as it will provide insights into the company’s financial health and potential returns for shareholders, impacting its market positioning and stakeholder interests.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Co is a company incorporated in Hong Kong, operating in the traditional Chinese medicine industry. It focuses on the production and distribution of Chinese medicinal products, catering to a market that values traditional healthcare solutions.
YTD Price Performance: 7.80%
Average Trading Volume: 1,225,781
Technical Sentiment Signal: Hold
Current Market Cap: HK$7.61B
Find detailed analytics on 3613 stock on TipRanks’ Stock Analysis page.